Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Resmed Inc (RMD)

Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 36,705,616
  • Shares Outstanding, K 145,941
  • Annual Sales, $ 5,146 M
  • Annual Income, $ 1,401 M
  • EBIT $ 1,792 M
  • EBITDA $ 2,028 M
  • 60-Month Beta 0.87
  • Price/Sales 7.13
  • Price/Cash Flow 22.44
  • Price/Book 5.99

Options Overview Details

View History
  • Implied Volatility 26.17% (+1.66%)
  • Historical Volatility 21.73%
  • IV Percentile 31%
  • IV Rank 16.02%
  • IV High 56.66% on 04/08/25
  • IV Low 20.36% on 08/13/25
  • Expected Move (DTE 14) 9.50 (3.70%)
  • Put/Call Vol Ratio 32.00
  • Today's Volume 66
  • Volume Avg (30-Day) 1,278
  • Put/Call OI Ratio 4.43
  • Today's Open Interest 25,810
  • Open Int (30-Day) 26,844
  • Expected Range 247.54 to 266.54

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 2.67
  • Number of Estimates 5
  • High Estimate 2.74
  • Low Estimate 2.62
  • Prior Year 2.43
  • Growth Rate Est. (year over year) +9.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
237.63 +8.26%
on 12/01/25
258.09 -0.32%
on 11/28/25
+12.04 (+4.91%)
since 11/05/25
3-Month
237.63 +8.26%
on 12/01/25
284.87 -9.69%
on 10/08/25
-19.79 (-7.14%)
since 09/05/25
52-Week
199.92 +28.68%
on 04/07/25
293.81 -12.44%
on 08/22/25
+17.85 (+7.46%)
since 12/05/24

Most Recent Stories

More News
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds

1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds

RMD : 257.72 (+2.47%)
NEOG : 6.01 (+1.35%)
CBSH : 52.67 (+0.02%)
Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

CORT : 84.98 (+0.38%)
ELAN : 21.93 (-0.27%)
LMAT : 83.88 (-2.12%)
PEN : 301.97 (+2.46%)
RMD : 257.72 (+2.47%)
Are Wall Street Analysts Predicting ResMed Stock Will Climb or Sink?

ResMed has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

$SPX : 6,873.69 (+0.24%)
RMD : 257.72 (+2.47%)
IHI : 63.65 (+0.54%)
1 Large-Cap Stock to Target This Week and 2 We Brush Off

1 Large-Cap Stock to Target This Week and 2 We Brush Off

STT : 124.05 (+1.79%)
DHI : 159.54 (-0.74%)
RMD : 257.72 (+2.47%)
1 S&P 500 Stock to Research Further and 2 We Turn Down

1 S&P 500 Stock to Research Further and 2 We Turn Down

BF.B : 30.30 (+2.82%)
RMD : 257.72 (+2.47%)
URI : 806.14 (-0.20%)
ResMed’s Q3 Earnings Call: Our Top 5 Analyst Questions

ResMed’s Q3 Earnings Call: Our Top 5 Analyst Questions

RMD : 257.72 (+2.47%)
RMD Q3 Deep Dive: ResMed Launches New Mask Platform and Invests in U.S. Operations

RMD Q3 Deep Dive: ResMed Launches New Mask Platform and Invests in U.S. Operations

RMD : 257.72 (+2.47%)
ResMed: Fiscal Q1 Earnings Snapshot

ResMed: Fiscal Q1 Earnings Snapshot

RMD : 257.72 (+2.47%)
ResMed (NYSE:RMD) Reports Q3 In Line With Expectations

ResMed (NYSE:RMD) Reports Q3 In Line With Expectations

RMD : 257.72 (+2.47%)
Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026

Revenue increased by 9% to $1.3 billion; up 8% on a constant currency basis  Gross margin up 290 bps to 61.5%; non-GAAP gross margin up 280 bps to 62.0% Income from operations increased 15%; non-GAAP income...

RMD.AX : 38.810 (+2.64%)
RMD : 257.72 (+2.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory...

See More

Key Turning Points

3rd Resistance Point 255.14
2nd Resistance Point 253.94
1st Resistance Point 252.73
Last Price 257.72
1st Support Level 250.32
2nd Support Level 249.12
3rd Support Level 247.91

See More

52-Week High 293.81
Fibonacci 61.8% 257.94
Last Price 257.72
Fibonacci 50% 246.86
Fibonacci 38.2% 235.79
52-Week Low 199.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar